Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+100.6%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+100.6%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
32.5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 383.56% |
| 2024 | 37.31% |
| 2023 | 64.06% |
| 2022 | -10.78% |
| 2021 | 14.46% |
| 2020 | 11.81% |
| 2019 | -15.31% |
| 2018 | -62.91% |
| 2017 | -17.78% |
| 2016 | -43.44% |